Results 141 to 150 of about 27,231 (235)
Effects of acute exercise and allopurinol administration on soluble urokinase plasminogen activator receptor (suPAR)
Sanchis Gomar F +6 more
core +1 more source
Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma. [PDF]
Zeng F +6 more
europepmc +1 more source
Aziz Gumus,1 Nejat Altintas,2 Halit Cinarka,1 Aynur Kirbas,3 Muge Haziroglu,1 Mevlut Karatas,1 Unal Sahin1 1Department of Pulmonary Medicine, School of Medicine, Recep Tayyip Erdogan University, Rize, Turkey; 2Department of Pulmonary Medicine ...
Kirbas A +6 more
core
The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review. [PDF]
Tucker TA, Idell S.
europepmc +1 more source
We have investigated plasmin mediated proteolysis associated with trophoblast invasion during early stages of pregnancy in the rhesus monkey. In situ hybridization and immunocytochemical localization were used to define the cellular and tissue ...
Ockleford, C.D. +8 more
core +1 more source
Soluble urokinase plasminogen activator receptor (suPAR) (ng/ml) in blood donors according to sex and age.
Christian Thorball (569556) +5 more
core +1 more source
Purpose of the study. Was to reveal the effect of urokinase gene knockout in male and female mice with transplanted B16/F10 melanoma on the functions of the fibrinolytic system units.Materials and methods. Male and female mice were used: main group with
E. M. Frantsiyants +11 more
doaj +1 more source
Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI. [PDF]
Azam TU +27 more
europepmc +1 more source
In this study we have used in situ hybridization with radiolabeled antisense RNA probes to examine the expression of mRNA for urokinase-type plasminogen activator and its receptor in histologic samples of squamous cell (n = 7) and basal cell (n = 7 ...
Ralfkiær, Elisabeth +4 more
core +1 more source
Activation of plasminogen to plasma is inhibited by preventing the binding of a receptor binding form of urokinase-type plasminogen activator to a urokinase-type plasminogen activator receptor in a mammal, thereby preventing the urokinase-type ...
Pollanen,, Jari +20 more
core

